High-risk HPV59 positivity can be treated clinically with antiviral drugs, such as interferon, and drugs to improve the vaginal environment, such as Povidone-based suppositories, etc. High-risk HPV59 positivity indicates a viral infection with human papillomavirus 59. If HPV59 infection is persistent for more than two years, it may cause the development of cervical cancer or cervical epithelial neoplasia. If the symptoms of cervical cancer are severe, antiviral treatment such as interferon can be administered to improve the vaginal resistance, and povidon suppositories can be used to relieve the internal environment of the vagina for treatment.